Skip to main content
. 2002 Aug;17(8):604–611. doi: 10.1046/j.1525-1497.2002.11048.x

Table 5.

Predictors of Time to First Readmission More Than 60 Days After Index Admission for Patients Alive 60 Days After Index Admission (Multivariable)

Any Readmission Cardiovascular Readmission
Hazard Ratio 95% CI P Value Hazard Ratio 95% CI P Value
Age 1.009 1.008 to 1.010 .0001 1.007 1.006 to 1.008 .0001
Gender (male versus female) 1.299 1.172 to 1.439 .0001 1.296 1.146 to 1.467 .0001
Race (white versus others) 0.921 0.894 to 0.948 .0001 0.885 0.856 to 0.916 .0001
Hypertension 0.973 0.952 to 0.995 .0153 1.036 1.009 to 1.063 .0078
Diabetes 1.076 1.048 to 1.104 .0001 1.102 1.068 to 1.136 .0001
Congestive heart failure 1.144 1.111 to 1.179 .0001 1.343 1.298 to 1.389 .0001
Hyperlipidemia 0.814 0.789 to 0.840 .0001 0.887 0.855 to 0.919 .0001
Atrial fibrillation 1.016 0.977 to 1.056 .4322 1.077 1.029 to 1.126 .0013
COPD 1.136 1.104 to 1.169 .0001 1.042 1.007 to 1.078 .0184
Stroke 0.895 0.789 to 1.014 .0824 0.930 0.800 to 1.080 .3422
Discharge diagnoses, n 1.065 1.060 to 1.071 .0001 1.061 1.055 to 1.067 .0001
Charlson Index 1.112 1.080 to 1.144 .0001 1.018 0.984 to 1.053 .3003
Cardiac catheterization at index 2.032 1.979 to 2.085 .0001 2.856 2.772 to 2.942 .0001
CABG or PTCA at index 1.283 1.243 to 1.325 .0001 1.475 1.426 to 1.527 .0001
CABG or PTCA within 60 days 0.695 0.663 to 0.728 .0001 0.544 0.516 to 0.574 .0001
Clinic visits within 60 days*
 Cardiology and General Medicine versus none 0.977 0.928 to 1.028 .3727 1.081 1.019 to 1.147 .0100
 Cardiology versus none 0.937 0.906 to 0.969 .0001 1.047 1.008 to 1.088 .0189
 General Medicine versus none 0.987 0.959 to 1.016 .3691 1.033 0.998 to 1.068 .0619
Region
 MW versus S 0.975 0.949 to 1.002 .0704 0.931 0.902 to 0.962 .0001
 NE versus S 0.951 0.921 to 0.983 .0029 0.882 0.849 to 0.917 .0001
 W versus S 0.952 0.924 to 0.980 .0010 0.924 0.893 to 0.957 .0001
*

Interaction between Cardiology and General Medicine not significant; P = .0937 and .9968.

COPD, chronic obstructive pulmonary disease; CABG, coronary artery bypass grafting; PTCA, percutaneous transluminal coronary angioplasty; MW, Midwest; NE, Northeast; S, South; W, West.